| |
|
|
|
Aquestive Therapeutics Inc  
|
|
5.29 0.71 (0.16%) |
03-01 16:00 |
|
Open: |
4.85 |
Pre close: |
4.58 |
Target:
|
7.09
|
|
High: |
5.345 |
Low: |
4.75 |
Resistance:
|
6.07
7.00
|
|
Volume: |
1,291,703 |
Market Cap: |
178M |
Support:
|
4.58
3.81
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.13
 |
MACD |
MACD(12,26):
|
-0.20  |
|
MA(20): |
5.73 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
5.88 |
Stochastic Oscillator |
%K(14,3):
|
13.43 |
|
MA(250): |
5.44 |
%D(3): |
16.21 |
|
Average Volume(K) |
3-Month: |
91068
|
52-Week |
High:
|
9.47 |
|
10-Days: |
100779 |
Low: |
1.41 |
|
RSI |
RSI(14):
|
45.33 |
Change(%): |
44.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.510 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
33.62 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-46.8 |
Shares Float (M) |
29.63 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.85 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-33.5 |
% Held by Institutions |
59.46 |
|
Forward EPS |
-2.610 |
Gross Profit (p.s.) |
0.959 |
Shares Short (K) |
1950 |
|
Book Value (p.s.) |
-1.090 |
EBITDA (p.s.) |
-1.013 |
P/E |
-3.50 |
|
Sales Per Share |
1.640 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.85 |
|
Profit Margin |
-87.18 |
Operating Cash Flow
(M) |
-42.52 |
P/S |
3.23 |
|
Operating Margin |
-67.40 |
Levered Free Cash Flow
(M) |
-19.72 |
P/CF |
-4.18 |
|
|
|
|
|
|
